Testing effectiveness (Phase 2)Study completedNCT03454750
What this trial is testing
Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)
Who this might be right for
Metastatic Castration Resistant Prostate Cancer68Ga-PSMA PET/CT Positive
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 143